Optinose

Developer of smart devices for nasal drug delivery

placeMorrisville, Pennsylvania, United States calendar_todayFounded 2000 groups132 employees language optinose.com

Registered entities

Innovation

14 patent families (11 granted) — focus: Human necessities; filing pace steady. Cited 2,260 times.

YearFilings
20141
20173
20201
20211
20239
20242
20258
20261

Investor mix

8 investors on record; lead investors include Avista Capital Partners, WFD Ventures, Fidelity Investments, Entrepreneurs Fund.

Investor typeCountShare
Venture capital338%
Private equity225%
Other / undisclosed338%
Coming soon